MakingORG, Inc. (CQCQ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MakingORG, Inc. (CQCQ) trades at $0.75 with AI Score 61/100 (Grade B+). MakingORG, Inc. specializes in purchasing and selling Acer truncatum bunge seed oil within the People's Republic of China. Market cap: $26.66M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CQCQ: CQCQ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CQCQ against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CQCQ: 2/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →MakingORG, Inc. (CQCQ) Healthcare & Pipeline Overview
MakingORG, Inc. operates in the healthcare sector, specializing in the distribution of Acer truncatum bunge seed oil within the People's Republic of China. The company supplies this raw material to third parties for the manufacturing of health products, positioning itself as a key supplier in a niche segment of the Chinese health and wellness market.
What Is the Investment Thesis for CQCQ?
MakingORG, Inc. operates in a niche segment of the Chinese healthcare market, distributing Acer truncatum bunge seed oil for health product manufacturing. The company's investment thesis hinges on its specialized product focus and its presence in the growing Chinese health and wellness sector. With a gross margin of 40.3%, the company demonstrates a healthy margin on its core sales. However, significant challenges are evident in its financial performance, notably a profit margin of -58.2%, indicating substantial unprofitability at the operational level. The company's small scale, with only 2 employees and a market capitalization of $26.66M, suggests inherent risks associated with micro-cap companies, including limited resources and potential for operational inefficiencies. Furthermore, its high Beta of 4.38 points to extreme market volatility, making it a high-risk proposition. The company's reliance on a single product and a single geographic market also presents concentration risks. Future growth would depend on increasing demand for Acer truncatum bunge related health products in China and expanding its customer base among manufacturers, but these opportunities are weighed against its current financial standing and operational limitations.
Based on FMP financials and quantitative analysis
CQCQ Key Highlights
- Market Capitalization: $0.03 billion, indicating a micro-cap company with a very small market valuation.
- Profit Margin: -58.2%, reflecting significant unprofitability and operational losses.
- Gross Margin: 40.3%, suggesting a reasonable margin on sales before accounting for operating expenses.
- Beta: 4.38, indicating extremely high volatility relative to the broader market.
- Operational Scale: Operates with a lean team of only 2 employees, highlighting a micro-enterprise structure.
Who Are CQCQ's Competitors?
CQCQ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| PEQSX Putnam Large Cap Value Fund | $43.95 | +1.31% | $51.40B | 47 |
| FEDDX Fidelity Emerging Markets Discovery Fd | $22.90 | +0.62% | $1.51B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| RWMBX American Funds Washington Mutual R2 | $65.59 | +0.74% | $147.31B | 46 |
| VQSRX Virtus KAR Small-Cap Value Fund | $25.02 | +0.68% | $582.06M | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CQCQ's Key Strengths?
- Niche product focus on Acer truncatum bunge seed oil, catering to a specialized market segment.
- Established presence and operational activities within the People's Republic of China.
- Gross margin of 40.3%, indicating a healthy margin on product sales before operating expenses.
What Are CQCQ's Weaknesses?
- Small operational scale with only 2 employees, potentially limiting capacity and resilience.
- Significant unprofitability, evidenced by a negative profit margin of -58.2%.
- High market volatility, with a Beta of 4.38, indicating substantial price fluctuations.
- Reliance on a single product and a single geographic market, creating concentration risk.
What Could Drive CQCQ Stock Higher?
- Increased demand for Acer truncatum bunge related health products in the People's Republic of China, driven by evolving consumer health trends.
- Securing new supply contracts or expanding existing agreements with third-party health product manufacturers in China.
- Any future public disclosure of financial results or operational updates, which would provide much-needed transparency to investors.
- Continued operational efficiency in sourcing and distributing Acer truncatum bunge seed oil within its niche market.
What Are the Key Risks for CQCQ?
- Financial-distress signal — its Altman Z-Score of -5.39 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Persistent unprofitability, evidenced by a profit margin of -58.2%, raising concerns about long-term financial viability.
- High market volatility, indicated by a Beta of 4.38, exposing investors to significant price fluctuations.
- Extreme concentration risk due to reliance on a single product (Acer truncatum bunge seed oil) and a single geographic market (China).
- Regulatory changes or increased scrutiny within the Chinese health product ingredient market could impact operations or demand.
- Intense competition from other raw material suppliers or the emergence of substitute ingredients affecting market share and pricing power.
- Operational limitations and execution risks inherent in a company with only two employees and a micro-cap structure.
What Are the Growth Opportunities for CQCQ?
- Increased Demand for Acer truncatum bunge related health products in China: The health and wellness market in the People's Republic of China continues to expand, driven by an aging population, rising disposable incomes, and increased health consciousness. As consumers seek natural and preventative health solutions, the demand for ingredients like Acer truncatum bunge seed oil, used in various health products, is anticipated to grow. MakingORG, Inc. is positioned to capitalize on this overarching market trend by supplying a key raw material. This organic market growth could translate into higher sales volumes for the company, assuming it can maintain its supply chain and competitive pricing.
- Expansion of Customer Base among Manufacturers: MakingORG, Inc. currently supplies Acer truncatum bunge seed oil to third-party manufacturers of health products in China. A significant growth opportunity lies in identifying and securing new manufacturing clients within this market. By expanding its roster of customers, the company can diversify its revenue streams and reduce reliance on a limited number of buyers. This strategy would involve targeted outreach, demonstrating reliable supply capabilities, and potentially offering competitive terms to attract new partners in the robust Chinese health product manufacturing sector.
- Volume Growth with Existing Customers: Deepening relationships with current third-party manufacturers in China presents another avenue for growth. By consistently delivering high-quality Acer truncatum bunge seed oil and ensuring reliable supply, MakingORG, Inc. can aim to become a primary or exclusive supplier for its existing clients. This could lead to increased order volumes, longer-term contracts, and potentially more favorable pricing agreements. Strengthening these relationships is crucial for stable revenue generation and leveraging established trust within its niche market.
- Supply Chain Efficiency and Cost Optimization: As a distributor of a specialized raw material, optimizing the supply chain for Acer truncatum bunge seed oil is a continuous growth driver. Improvements in sourcing, logistics, and inventory management can lead to reduced operational costs and enhanced gross margins. For a company with a current gross margin of 40.3%, further efficiencies could significantly impact overall profitability. Streamlining these processes would allow MakingORG, Inc. to offer more competitive pricing or improve its own bottom line, strengthening its market position.
- Deepening Market Penetration within the Niche: MakingORG, Inc.'s singular focus on Acer truncatum bunge seed oil in China allows for deep specialization. A growth opportunity exists in capturing a larger percentage of the total available market for this specific ingredient within China. This could involve understanding all potential applications and manufacturers, even beyond current "health products," if the ingredient has broader industrial uses. By becoming the dominant or most recognized supplier for this specific seed oil, the company could secure a stronger competitive advantage and command greater market influence.
What Opportunities Does CQCQ Have?
- Growing health and wellness market in China, potentially increasing demand for its specialized product.
- Opportunity to expand its customer base by securing new manufacturing clients in China.
- Potential for increased sales volume and deeper penetration with existing third-party manufacturers.
What Threats Does CQCQ Face?
- Ongoing unprofitability poses a significant threat to long-term financial sustainability.
- Regulatory changes in China concerning health product ingredients or distribution.
- Intense competition from other raw material suppliers or the emergence of substitute ingredients.
- Supply chain disruptions or fluctuations in the availability or cost of Acer truncatum bunge seed oil.
- High market volatility inherent to its micro-cap and OTC-listed status.
What Are CQCQ's Competitive Advantages?
- Specialized focus on Acer truncatum bunge seed oil, creating a niche expertise in this specific botanical ingredient.
- Established operational presence and supply chain within the Chinese market for its core product.
- Existing relationships with manufacturers of Acer truncatum bunge related health products in China.
What Does CQCQ Do?
MakingORG, Inc., originally incorporated in 2012 under the name Drimex Inc., underwent a significant corporate rebranding in August 2014, adopting its current identity. Headquartered in Walnut, California, the company's operational focus is exclusively directed towards the People's Republic of China. Here, MakingORG, Inc. has established itself as a specialized entity in the procurement and distribution of Acer truncatum bunge seed oil. This particular seed oil is a key raw material, which the company supplies to various third-party manufacturers across China. These manufacturers, in turn, integrate the Acer truncatum bunge seed oil into the formulation and production of a diverse range of health products. MakingORG, Inc. effectively serves as a critical intermediary in the supply chain, bridging the gap between the source of this botanical ingredient and the manufacturers who transform it into consumer-ready health goods. The company's business model is centered on its expertise in sourcing and distributing this specific natural product, catering to the growing demand for health-related ingredients within the Chinese market. Its strategic decision to concentrate on a singular, specialized product within a defined geographical market allows it to develop deep knowledge and potentially strong relationships within this niche. While its corporate base is in the United States, its entire commercial activity, from purchasing to selling, is executed within China, signifying a unique operational structure. This targeted approach positions MakingORG, Inc. not as a direct consumer product manufacturer, but as an essential business-to-business supplier, enabling the broader health product industry in China to access specialized raw materials for their offerings. The company's evolution from its founding in 2012 to its current specialized role demonstrates a clear strategic pivot towards a focused market segment within the vast Chinese healthcare landscape, emphasizing its role in supporting the development of Acer truncatum bunge related health products.
What Products and Services Does CQCQ Offer?
- Purchases Acer truncatum bunge seed oil from various sources.
- Sells this specialized seed oil to industrial clients.
- Operates exclusively within the People's Republic of China for its sales and distribution.
- Supplies raw materials to third-party manufacturers.
- These manufacturers produce health products related to Acer truncatum bunge.
- Functions as a business-to-business distributor in the healthcare supply chain.
- Focuses on a niche market for a specific botanical ingredient.
- Was formerly known as Drimex Inc. before changing its name in 2014.
How Does CQCQ Make Money?
- Sources Acer truncatum bunge seed oil from suppliers.
- Distributes the procured seed oil to third-party health product manufacturers in China.
- Generates revenue through the direct sale of this specialized raw material.
- Operates as a focused intermediary in the supply chain for natural health ingredients.
What Industry Does CQCQ Operate In?
MakingORG, Inc. operates within the broader Healthcare sector, specifically positioned in the Medical - Distribution industry, with a highly specialized focus on the Chinese market. The company's niche is the distribution of Acer truncatum bunge seed oil, a raw material for health products. This places it within the supply chain for the burgeoning health and wellness market in China, which has seen consistent growth driven by increasing consumer awareness of health and preventative care. The competitive landscape for specialized raw material suppliers in China can be fragmented, with numerous domestic and international players vying for contracts with health product manufacturers. MakingORG, Inc. differentiates itself through its singular focus on Acer truncatum bunge seed oil, aiming to be a dedicated supplier in this specific botanical ingredient segment. Its operational model is distinct from larger, more diversified medical distributors that handle a wide array of pharmaceutical or medical device products. Instead, it targets a specific ingredient market, where success depends on reliable sourcing, efficient logistics, and established relationships with a limited set of specialized manufacturers. The company's small scale, however, means it operates at the periphery of the mainstream medical distribution industry, facing challenges typical of micro-cap entities in a competitive environment.
Who Are CQCQ's Key Customers?
- Third-party manufacturing companies specializing in health products.
- Producers of Acer truncatum bunge related health products.
- Industrial clients within the People's Republic of China's health and wellness sector.
Company Profile
MakingORG, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Walnut, US. The company is led by CEO Juanzi Cui. CQCQ has traded publicly since 2014.
F-Score 3/9Financial Health
MakingORG, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -5.39 places it in the distress zone, a signal of elevated financial risk.
ROE 12%Key Financial Metrics
Return on equity for MakingORG, Inc. stands at 11.7%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.3%, the inverse of the P/E and a quick read on earnings relative to price.
CQCQ Valuation & Market Position
With a $26.66M market cap, MakingORG, Inc. sits in the micro-cap segment of the market. Relative to its peer group, CQCQ's quantitative score of 61/100 is above the peer average of 47/100.
CQCQ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that leadership believes in the growth potential ahead.
- Community sentiment has shifted positively, with discussions highlighting innovative product developments that could drive market interest.
- Recent partnerships announced by MakingORG, Inc. have generated buzz, suggesting a strong strategic direction that aligns with market needs.
- Analysts have noted an increase in social media mentions, reflecting a growing interest and excitement around the brand and its offerings.
Bear Case
- Despite the positive sentiment, some analysts express concerns over the company's cash flow situation, which could hinder growth plans.
- There have been mixed reviews from the community regarding recent product launches, with some expressing skepticism about their market viability.
- Recent regulatory challenges in the industry have raised red flags, creating uncertainty around the company's operational environment.
- Social sentiment shows a segment of investors worried about potential competition entering the market, which could impact MakingORG's market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CQCQ Latest News
No recent news available for CQCQ.
CQCQ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CQCQ.
Price Targets
Wall Street price target analysis for CQCQ.
CQCQ MoonshotScore
What does this score mean?
The MoonshotScore rates CQCQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Juanzi Cui
CEO
Juanzi Cui serves as a key leader at MakingORG, Inc., a company operating in the specialized distribution of Acer truncatum bunge seed oil in China. While specific details regarding Ms. Cui's educational background, prior career history, or previous roles before joining MakingORG, Inc. are not publicly disclosed, her current position involves managing the company's lean operational structure, which consists of two employees. Her role is central to the strategic execution of the company's business model, overseeing the procurement and distribution activities within the People's Republic of China. The company's focused approach on a single product and market suggests a leadership committed to niche market penetration.
Track Record: Under Juanzi Cui's leadership, MakingORG, Inc. has maintained its specialized focus on Acer truncatum bunge seed oil distribution in China since its name change in 2014. Her management involves navigating the complexities of international trade and local distribution within the Chinese health product ingredient market. Key decisions would include establishing and maintaining supplier relationships for the seed oil and managing client relationships with third-party health product manufacturers. The company's continued operation, despite its micro-cap status and negative profitability, reflects ongoing operational management.
CQCQ OTC Market Information
MakingORG, Inc. trades on the 'OTC Other' tier of the OTC market. This tier is typically for companies that do not meet the listing requirements for OTCQX or OTCQB, or that choose not to provide current information to OTC Markets Group. Unlike major exchanges such as NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and minimum share prices, 'OTC Other' has minimal to no ongoing disclosure requirements. This classification often indicates a company with very limited public information, making it challenging for investors to conduct thorough due diligence and assess its financial health or operational activities comprehensively.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Public Disclosure: The 'Unknown' disclosure status means investors lack critical financial and operational information, hindering informed decision-making.
- Extremely Low Liquidity: Trading on 'OTC Other' with a tiny market cap results in wide bid-ask spreads and difficulty in buying or selling shares.
- Price Volatility and Manipulation: OTC markets, especially lower tiers, are more susceptible to extreme price fluctuations and potential market manipulation due to lack of transparency and low trading volumes.
- Absence of Regulatory Oversight: Compared to major exchanges, regulatory oversight on the 'OTC Other' tier is minimal, offering fewer protections for investors.
- Operational Risks of a Micro-Cap: The company's small scale (2 employees) and negative profit margin present significant operational and financial sustainability risks.
- Attempt to locate any available financial statements or corporate filings, however limited.
- Research the background and track record of Juanzi Cui and any other key personnel.
- Independently verify the existence and nature of the company's operations in China, including its suppliers and customers.
- Assess the market demand and competitive landscape for Acer truncatum bunge seed oil in China.
- Understand the regulatory environment for health product ingredients in China and any potential impacts.
- Evaluate the company's capital structure and any outstanding debt or financing arrangements.
- Consider the long-term viability of a business with a persistent negative profit margin and minimal employee count.
- Incorporated in 2012, indicating a history of operation.
- Underwent a name change in 2014, suggesting corporate activity and evolution.
- Has a named leader, Juanzi Cui, providing a point of contact for management.
- Focuses on a specific, identifiable product (Acer truncatum bunge seed oil) and geographic market (China).
- Operates within a defined industry (Medical - Distribution) and sector (Healthcare).
Common Questions About CQCQ (Healthcare)
What is Acer truncatum bunge seed oil and its significance in the health product market?
Acer truncatum bunge seed oil is a specialized botanical ingredient that MakingORG, Inc. procures and distributes within the People's Republic of China. While the specific health benefits or applications are not detailed, its use by third-party manufacturers for 'Acer truncatum bunge related health products' suggests its value in the natural health and wellness sector. In China, there's a growing consumer preference for traditional and natural ingredients in health supplements, functional foods, and other wellness products. MakingORG, Inc.'s role is to supply this raw material, indicating its importance as a component in a range of health-focused consumer goods, supporting a segment of the Chinese health industry.
How does MakingORG, Inc. manage its supply chain for Acer truncatum bunge seed oil in China?
MakingORG, Inc. manages its supply chain by focusing on the procurement and distribution of Acer truncatum bunge seed oil specifically within the People's Republic of China. The company's operational model involves sourcing this specialized raw material, likely from producers or aggregators, and then distributing it to various third-party manufacturers across China. As a lean organization with only two employees, its supply chain management would emphasize efficiency and established relationships with both suppliers and customers. This targeted approach allows the company to concentrate its resources on optimizing the flow of this particular ingredient from source to its industrial clients for health product manufacturing.
What are the primary financial challenges facing MakingORG, Inc. as an OTC-listed company?
MakingORG, Inc. faces several significant financial challenges, particularly as an 'OTC Other' listed company. A primary concern is its substantial unprofitability, reflected by a profit margin of -58.2%, indicating that expenses far outweigh revenues. Despite a gross margin of 40.3%, operational costs are clearly unsustainable. Its micro-cap status ($26.66M market cap) and limited employee count (2) suggest minimal resources and potential for operational fragility. Furthermore, its OTC listing implies limited access to capital markets for financing, and the 'Unknown' disclosure status severely restricts investor access to crucial financial data, exacerbating investment risk and making financial assessment difficult.
What are the key factors to evaluate for CQCQ?
MakingORG, Inc. (CQCQ) holds an AI score of 61/100 (moderate). Not financial advice.
How frequently does CQCQ data refresh on this page?
CQCQ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CQCQ's recent stock price performance?
MakingORG, Inc. (CQCQ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche product focus on Acer truncatum bunge seed oil, catering to a specialized market segment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CQCQ overvalued or undervalued right now?
Valuing MakingORG, Inc. (CQCQ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CQCQ?
Before investing in MakingORG, Inc. (CQCQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited public financial data beyond basic metrics. Specific details on operational scale, customer base, and competitive landscape are not publicly available. CEO background and track record are not detailed in provided sources.